Somatic mRNA Turnover Mutants Implicate Tristetraprolin in the Interleukin-3 mRNA Degradation Pathway
暂无分享,去创建一个
[1] H. Diggelmann,et al. Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eucaryotic cells , 1984, Molecular and cellular biology.
[2] G. Shaw,et al. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.
[3] B. Beutler,et al. Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Cole,et al. Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3' untranslated sequences , 1987, Molecular and cellular biology.
[5] G. Schuler,et al. GM-CSF and oncogene mRNA stabilities are independently regulated in trans in a mouse monocytic tumor , 1988, Cell.
[6] N. Gough. Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. , 1988, Analytical biochemistry.
[7] V. Sukhatme,et al. Nucleotide sequence of a cDNA encoding TIS11, a message induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate. , 1989, Oncogene.
[8] G. Stark,et al. Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway , 1989, Molecular and cellular biology.
[9] M. Greenberg,et al. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. , 1989, Genes & development.
[10] H. Hirsch,et al. Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Ross,et al. Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component , 1989, Molecular and cellular biology.
[12] V. Kindler,et al. A v-H-ras-dependent hemopoietic tumor model involving progression from a clonal stage of transformation competence to autocrine interleukin 3 production , 1989, Molecular and cellular biology.
[13] H. Land,et al. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.
[14] N. Andrews,et al. Positive and negative elements regulate human interleukin 3 expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[15] G. Brewer,et al. An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro , 1991, Molecular and cellular biology.
[16] G. Stark,et al. Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons , 1991, Molecular and cellular biology.
[17] R. Wisdom,et al. The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. , 1991, Genes & development.
[18] H. Herschman,et al. A corrected sequence for the predicted protein from the mitogen-inducible TIS11 primary response gene. , 1991, Oncogene.
[19] P. Erb,et al. Functional heterogeneity of CD4-positive T-cell subsets: the correlation between effector functions and lymphokine secretion is limited. , 1991, Cellular immunology.
[20] G. Stark,et al. High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[21] H. Hirsch,et al. Mast cells sensitive to v-H-ras transformation are hyperinducible for interleukin 3 expression and have lost tumor-suppressor activity. , 1992, Oncogene.
[22] J. Gnarra,et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.
[23] W Zhang,et al. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1 , 1993, Molecular and cellular biology.
[24] M. Greenberg,et al. The destabilizing elements in the coding region of c-fos mRNA are recognized as RNA , 1993, Molecular and cellular biology.
[25] H. Hirsch,et al. Suppressible and nonsuppressible autocrine mast cell tumors are distinguished by insertion of an endogenous retroviral element (IAP) into the interleukin 3 gene , 1993, The Journal of experimental medicine.
[26] H. Hirsch,et al. Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA , 1994, Nature.
[27] G. Stoecklin,et al. Functional hierarchy of AUUUA motifs in mediating rapid interleukin-3 mRNA decay. , 1994, The Journal of biological chemistry.
[28] J. Ross,et al. mRNA stability in mammalian cells. , 1995, Microbiological reviews.
[29] C. Y. Chen,et al. AU-rich elements: characterization and importance in mRNA degradation. , 1995, Trends in biochemical sciences.
[30] N. Andrews,et al. Multiple Proteins Interact with the Nuclear Inhibitory Protein Repressor Element in the Human Interleukin-3 Promoter (*) , 1995, The Journal of Biological Chemistry.
[31] H. Hirsch,et al. Interleukin-3 mRNA Stabilization by a trans-Acting Mechanism in Autocrine Tumors Lacking Interleukin-3 Gene Rearrangements (*) , 1995, The Journal of Biological Chemistry.
[32] Roy Parker,et al. Degradation of mRNA in eukaryotes , 1995, Cell.
[33] M J Thompson,et al. Phosphorylation of Tristetraprolin, a Potential Zinc Finger Transcription Factor, by Mitogen Stimulation in Intact Cells and by Mitogen-activated Protein Kinase in Vitro(*) , 1995, The Journal of Biological Chemistry.
[34] B. Haynes,et al. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. , 1996, Immunity.
[35] S. Peltz,et al. Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. , 1996, Annual review of biochemistry.
[36] W. Kaelin,et al. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[37] R. Klausner,et al. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[38] Anne Wright,et al. Cloning and Characterization of HuR, a Ubiquitously Expressed Elav-like Protein (*) , 1996, The Journal of Biological Chemistry.
[39] J. Laubach,et al. Cooperation between Core Binding Factor and Adjacent Promoter Elements Contributes to the Tissue-specific Expression of Interleukin-3* , 1996, The Journal of Biological Chemistry.
[40] J. Steitz,et al. Identification of HuR as a protein implicated in AUUUA‐mediated mRNA decay , 1997, The EMBO journal.
[41] A. Levy,et al. Hypoxic Stabilization of Vascular Endothelial Growth Factor mRNA by the RNA-binding Protein HuR* , 1998, The Journal of Biological Chemistry.
[42] P. Blackshear,et al. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. , 1998, Science.
[43] P. Blackshear,et al. Feedback Inhibition of Macrophage Tumor Necrosis Factor-α Production by Tristetraprolin , 1998 .
[44] A. Shyu,et al. RNA stabilization by the AU‐rich element binding protein, HuR, an ELAV protein , 1998, The EMBO journal.
[45] C. Moroni,et al. c‐jun N‐terminal kinase is involved in AUUUA‐mediated interleukin‐3 mRNA turnover in mast cells , 1998, The EMBO journal.
[46] J. Steitz,et al. Overexpression of HuR, a nuclear–cytoplasmic shuttling protein, increases the in vivo stability of ARE‐containing mRNAs , 1998, The EMBO journal.
[47] C. Y. Chen,et al. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. , 1999, Genes & development.
[48] P. Blackshear,et al. Evidence that Tristetraprolin Binds to AU-Rich Elements and Promotes the Deadenylation and Destabilization of Tumor Necrosis Factor Alpha mRNA , 1999, Molecular and Cellular Biology.
[49] M. Gstaiger,et al. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. , 1999, Genes & development.
[50] C. Moroni,et al. Calcium-Dependent and Oncogenic IL-3 mRNA Stabilization can be Distinguished Pharmacologically and by Sequence Requirements in the 3′UTR , 2000, Growth factors.